J INTS BIO
PrivateLast Round
Grant
Jul 2, 2026
Total Funding Raised
$5.41M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
J INTS BIO is a biotechnology company that specializes in the development of innovative anti-cancer and orphan drugs, particularly targeted therapies for non-small cell lung cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
J INTS BIO Comparables
Compare J INTS BIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Therapex | 95% | |
| RedCloud Bio | 90% | |
| BlossomHill Therapeutics | 81% | |
J INTS BIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 2, 2026 | ||||
| Series B | Sep 30, 2023 | ||||
| Corporate Funding | Nov 1, 2021 |
J INTS BIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anda Asia Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
Secured $2.22M in grant funding.
- Nov 1, 2021
Raised $1.69M from Yuhan Corporation
J INTS BIO Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about J INTS BIO's valuation, stock price, and market status.